Azilsartan Kamedoxomil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 17 USDMF, 10 JDMF, 11 EU WC, 15 KDMF, 6 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

33 Intermediates Suppliers

33 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 6 FDA Orange Book, 16 Europe, 4 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 40MG MEDOXOMIL, TABLET;ORAL - EQ 80MG MEDOXOMIL, TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG, TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 40 Fillers, Diluents & Binders, 23 Direct Compression, 21 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 12 Taste Masking, 12 Granulation, 7 Film Formers & Plasticizers, 5 Coloring Agents, 5 Empty Capsules, 4 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 2 Emulsifying Agents, 1 Solubilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 8 Annual Reports

MARKET PLACE

17 APIs

17 APIs

PATENTS & EXCLUSIVITIES

16 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 Others

10 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 202331 / DOSAGE - TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
AZILSARTAN KAMEDOXOMIL(UNII: WEC6I2K1FC) (AZILSARTAN - UNII:F9NUX55P23)	AZILSARTAN	40mg \| 40mg
chlorthalidone(UNII: Q0MQD1073Q) (chlorthalidone - UNII:Q0MQD1073Q)	chlorthalidone	25mg \| 12.5mg

Inactive Ingredients

Ingredient Name	Takeda Pharmaceuticals America, Inc.
alcohol(3K9958V90M)
butyl alcohol(8PJ61P6TS3)
cellulose, microcrystalline(OP1R32D61U)
CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
ferric oxide red(1K09F3G675)
ferrosoferric oxide(XM0M87F357)
fumaric acid(88XHZ13131)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
hypromelloses(3NXW29V3WO)
magnesium stearate(70097M6I30)
mannitol(3OWL53L36A)
polyethylene glycol 8000(Q662QK8M3B)
shellac(46N107B71O)
sodium hydroxide(55X04QC32I)
talc(7SEV7J4R1U)
titanium dioxide(15FIX9V2JP)
water(059QF0KO0R)

Drug Product Composition: Azilsartan Kamedoxomil